IP Verse

Sustained Release Formulations Using Non-Aqueous Carriers

PatentPatent Analysis

EP2341905

AMYLIN PHARMACEUTICALS
Application Number
EP09812292A
Filing Date
Sep 4, 2009
Status
Patent Maintained As Amended
Aug 11, 2023
Grant Date
Sep 13, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2347762B1

Bibliography

The patent EP2341905B2 was granted to Amylin Pharmaceuticals on Sep 13, 2023 following the initial filing on Sep 4, 2009 under the application number EP09812292A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

INSTONEJan 28, 2021ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents